PRKAA1 and breast carcinoma: Novel studies were reviewed from the PubMed, Web of Science, Medline, and Scopus databases to provide evidence to support AMPK as a potential therapeutic target for the treatment of breast cancer and to inspire novel target discoveries to manage breast cancer in the future.